Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capecitabine in Recurrent High Grade Gliomas
NCT00717197Phase 2Completed
- Sponsor
- University of Florida
- Start
- Jul 2008
- Primary completion
- Mar 2012
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine in high-grade glioma (HGG), sponsored by University of Florida. Started Jul 2008; status: completed.
02
Drugs
capecitabine
03
Conditions
high-grade glioma (HGG)
Beyond the preview
Go deeper on NCT00717197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00717197.